brusatol has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, J; Dou, Y; Li, Q; Lin, G; Nie, J; Su, Z; Wang, T; Xie, J; Xie, Y; Zeng, H | 1 |
| Dai, N; Guo, P; He, Q; Hong, Z; Xiang, Y; Ye, R; Zhang, Q | 1 |
| Alghanem, AF; Bryan, HK; Copple, IM; Cross, MJ; Dunn, K; Edge, GT; Ellis, EC; Goldring, CE; Ingelman-Sundberg, M; Kitteringham, NR; Lai, ZQ; Lin, ZX; Malik, HZ; Olayanju, A; Park, BK; Sanderson, CM; Sison, RL; Wong, MW | 1 |
3 other study(ies) available for brusatol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Brucea; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Male; Mice; MicroRNAs; Plant Oils; Quassins; Signal Transduction; Tumor Burden; Tumor Suppressor Protein p53 | 2021 |
Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quassins; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2018 |
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.
Topics: Animals; Apoptosis; Autophagy; Blotting, Western; Brucea; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Hepatocytes; Humans; Liver Neoplasms; Mice; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Quassins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2015 |